IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Darwin Global Management, Ltd.

Q1 2021 Holdings

Filed 2021-05-17 | 12 holdings | $143.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Bridgebio Pharma Inc(BBIO)COM10806X102$128.8M2,090,14989.7%
Arvinas Inc(ARVN)COM04335A105$9.3M140,5116.5%
C4 Therapeutics Inc(CCCC)COM STK12529R107$5.2M140,0343.6%
Acceleron Pharma Inc(XLRN)COM00434H108$204.1K1,505,0120.1%
Fate Therapeutics Inc(FATE)COM31189P102$113.0K1,370,1330.1%
Relay Therapeutics Inc(RLAY)COM75943R102$27.1K782,4710.0%
Macrogenics Inc(MGNX)COM556099109$9.1K286,1950.0%
Generation BIO Co(GBIOGBX)COM37148K100$6.2K219,3580.0%
Keros Therapeutics Inc(KROS)COM492327101$5.3K86,8870.0%
Immunovant Inc(IMVT)COM45258J102$1.1K65,8490.0%
Inhibrx Inc(INBXUSD)COM45720L107$99849,7090.0%
Fulcrum Therapeutics Inc(FULC)COM359616109$58749,8680.0%